Top Story

Breast reconstruction complications higher among women who underwent bilateral mastectomy

September 2, 2014

Read the Perspective from Harold J. Burstein, MD, PhD

Women who underwent bilateral mastectomy experienced higher rates of complications within 30 days of autologous or implant-based reconstruction than those who underwent unilateral mastectomy, according to study results presented at the Breast Cancer Symposium.

“We think this information is really critical to guide women who are contemplating having a double mastectomy,” Mark Sisco, MD, clinical assistant professor of surgery at the University of Chicago Pritzker School of Medicine, said during a press conference. “[Although] generally very safe, double mastectomy definitely increases the rate of certain complications. While each woman will interpret these findings differently, they really should be discussed and considered.”

Meeting News CoveragePerspective

Angelina Jolie’s preventive mastectomy doubled one center’s referrals for genetic testing

September 2, 2014
The number of genetic testing referrals nearly doubled at one center after Angelina Jolie publicly announced her decision to undergo preventive double mastectomy…
Industry News

Enrollment starts in OPTIMA global study of ThermoDox as HCC therapy

September 2, 2014
The first patient enrolled in the OPTIMA study for primary liver cancer will be studied at the Kyungpook National University Hospital in South Korea, according to a news…
In the Journals

BRCA2 mutation associated with shorter survival in screen-detected prostate cancer

September 2, 2014
Men with screen-detected prostate cancer who harbor mutations in the BRCA2 gene demonstrated poorer-than-expected prognosis, according to study results.Prior research…
More News Headlines »

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »